Greater numbers and sizes of muscle bundles in the breast and leg muscles of broilers compared to layer chickens.

Autor: Lee B; Department of Animal Sciences, The Ohio State University, Columbus, OH, United States.; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju-si, Gyeongsangbuk-do, Republic of Korea., Kim DH; Department of Animal Sciences, The Ohio State University, Columbus, OH, United States., Lee J; Department of Animal Sciences, The Ohio State University, Columbus, OH, United States., Cressman MD; Department of Animal Sciences, The Ohio State University, Columbus, OH, United States., Choi YM; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju-si, Gyeongsangbuk-do, Republic of Korea., Lee K; Department of Animal Sciences, The Ohio State University, Columbus, OH, United States.

Publikováno v: Frontiers in physiology [Front Physiol] 2023 Oct 09; Vol. 14, pp. 1285938. Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023).

A Non-purine Xanthine Oxidoreductase Inhibitor Reduces Albuminuria in Patients with DKD: A Randomized Controlled Trial.

Autor: Bakris GL; Medicine, The University of Chicago, Chicago, Illinois., Mikami H; Teijin America, Inc., New York, New York., Hirata M; Teijin America, Inc., New York, New York., Nakajima A; Pharmaceutical Development Administration Department, Teijin Pharma Limited, Tokyo, Japan., Cressman MD; Cardiovascular, Metabolic, Endocrine and Renal, Labcorp Drug Development, Inc., Princeton, New Jersey.

Publikováno v: Kidney360 [Kidney360] 2021 Jun 30; Vol. 2 (8), pp. 1240-1250. Date of Electronic Publication: 2021 Jun 30 (Print Publication: 2021).

Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.

Autor: Hanrahan JP; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., de Boer IH; Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington., Bakris GL; Department of Medicine, Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, Illinois., Wilson PJ; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Wakefield JD; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Seferovic JP; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Chickering JG; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Chien YT; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Carlson K; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Cressman MD; Cardiovascular/Metabolic Unit, Covance Inc., Princeton, New Jersey., Currie MG; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Milne GT; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts., Profy AT; Cyclerion Therapeutics, Inc., Cambridge, Massachusetts.

Publikováno v: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2020 Dec 31; Vol. 16 (1), pp. 59-69. Date of Electronic Publication: 2020 Dec 16.

Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.

Autor: Ballantyne CM; Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: cmb@bcm.edu., Shah S; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Kher U; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Hunter JA; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Gill GG; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Cressman MD; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Ashraf TB; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Johnson-Levonas AO; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey., Mitchel YB; Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey.

Publikováno v: The American journal of cardiology [Am J Cardiol] 2017 Feb 01; Vol. 119 (3), pp. 388-396. Date of Electronic Publication: 2016 Nov 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.